HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $16 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Arthur He has reiterated a Buy rating on Solid Biosciences (NASDAQ:SLDB) and maintained a $16 price target.
May 20, 2024 | 11:27 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Arthur He has reiterated a Buy rating on Solid Biosciences and maintained a $16 price target.
The reiteration of a Buy rating and the maintenance of a $16 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100